New dimensions in vascular engineering: opportunities for cancer biology

Sina Y Rabbany1, Daylon James, Shahin Rafii

  • 1Department of Genetic Medicine, Weill Cornell Medical College, Howard Hughes Medical Institute, New York, New York 10065, USA. sir2007@med.cornell.edu

Insights

Tissue engineering platforms can better mimic tumor microenvironments than traditional methods. This approach allows for more accurate studies of tumor angiogenesis and potential cancer therapeutics.

Area of Science:

  • Biomedical Engineering
  • Cancer Biology
  • Tissue Engineering

Background:

  • Angiogenesis is crucial for tissue growth and a target for cancer therapies.
  • Current antiangiogenic treatments show limited success, potentially due to inadequate research models.
  • Traditional 2D cell cultures do not replicate the complex in vivo tumor architecture.

Purpose of the Study:

  • To investigate tumor angiogenesis using advanced tissue engineering techniques.
  • To develop in vitro models that more accurately mimic the tumor microenvironment.
  • To provide a framework for studying tumorigenesis under pathophysiologically relevant conditions.

Main Methods:

  • Manipulation of oxygen concentration within engineered tissues.
  • Utilizing three-dimensionality in cell cultures.
  • Controlling cell-extracellular matrix interactions.
  • Employing novel tissue engineering platforms.

Main Results:

  • Engineered microenvironments closely approximate in vivo conditions for tumor angiogenesis.
  • Advanced models allow for more realistic study of factors influencing tumor growth.
  • This approach enhances the study of biophysical and biochemical aspects of angiogenesis.

Conclusions:

  • Novel tissue engineering platforms offer a superior framework for studying tumor angiogenesis.
  • These advanced in vitro models can overcome limitations of 2D cultures.
  • This research paves the way for more effective development of cancer therapeutics targeting angiogenesis.